Monument Capital Management Purchases New Shares in Sabra Healthcare REIT, Inc. $SBRA

Monument Capital Management purchased a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 14,974 shares of the real estate investment trust’s stock, valued at approximately $276,000.

A number of other institutional investors have also recently modified their holdings of SBRA. SVB Wealth LLC acquired a new stake in shares of Sabra Healthcare REIT during the 1st quarter worth $34,000. UMB Bank n.a. grew its holdings in shares of Sabra Healthcare REIT by 379.6% during the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock worth $36,000 after purchasing an additional 1,621 shares in the last quarter. Wealth Preservation Advisors LLC acquired a new stake in shares of Sabra Healthcare REIT during the 1st quarter worth $38,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Sabra Healthcare REIT by 61.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust’s stock worth $49,000 after purchasing an additional 1,065 shares in the last quarter. Finally, Anchor Investment Management LLC acquired a new stake in shares of Sabra Healthcare REIT during the 1st quarter worth $58,000. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Price Performance

Shares of SBRA stock opened at $17.74 on Friday. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.03. The company has a market cap of $4.25 billion, a P/E ratio of 23.34, a P/E/G ratio of 1.20 and a beta of 0.85. The business has a fifty day simple moving average of $18.76 and a 200 day simple moving average of $18.17.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating the consensus estimate of $0.36 by $0.02. The firm had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period last year, the company earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were given a $0.30 dividend. The ex-dividend date was Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 6.8%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 157.89%.

Analyst Ratings Changes

Several research firms have recently issued reports on SBRA. Truist Financial increased their target price on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a report on Tuesday, September 2nd. Weiss Ratings reissued a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday. Scotiabank upped their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research report on Monday, June 23rd. JMP Securities upped their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research report on Wednesday, August 6th. Finally, Cantor Fitzgerald initiated coverage on Sabra Healthcare REIT in a research report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $20.71.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.